期刊文献+

儿童外周神经母细胞性肿瘤临床病理因素与预后的相关性 被引量:5

Correlation between clinicopathological factors and prognosis in children’s peripheral neuroblastic tumors
下载PDF
导出
摘要 目的:探讨儿童外周神经母细胞性肿瘤临床病理因素与预后的相关性。方法:收集119例外周神经母细胞性肿瘤患儿的年龄、性别、发病部位、临床分期、病理类型、核碎裂指数(mitosis karyorrhexis index,MKI)、Ki-67指数、治疗方式以及预后情况,通过绘制Kaplan-Meier生存曲线、进行Log-rank χ^2检验以及Cox回归模型分析,探讨影响患儿预后的相关因素。结果:119例患儿中男72例、女47例,年龄平均28.07个月,生存时间平均48.74个月。单因素分析显示年龄、部位、临床分期、Ki-67指数及治疗方式与预后有一定相关性,多因素分析显示临床分期与治疗方式是预后的独立影响因素(P<0.05)。结论:外周神经母细胞性肿瘤儿童常见且病死率高,尽早诊断、明确分期,并综合检查结果制订合适的治疗方式,对于改善患儿预后具有一定的临床意义。 Objective:To investigate the correlation between clinicopathological factors and prognosis in children’s peripheral neuroblastic tumors.Methods:The age,sex,location,clinical stage,pathological type,mitosis karyorrhexis index(MKI),Ki-67 index,treatment and prognosis of peripheral neuroblastic tumors in 119 cases were collected.Then Kaplan-Meier survival curves were drawn,with the Log-rank χ^2 test and Cox regression model were used to explore the factors that may influence the prognosis of patients.Results:There were 72 boys and 47 girls with an average age of 28.07 months and an average survival time of 48.74 months.Univariate analysis showed that age,location,clinical stage,Ki-67 index and treatment were associated with prognosis.While multivariate analysis showed that clinical stage and treatment were independent prognostic factors(P<0.05).Conclusion:Peripheral neuroblastic tumors,which are common in pediatric patients,usually have a high mortality rate.Early diagnosis and clear staging,combining with appropriate treatments result from comprehensive examinations,may have a certain clinical significance for improving the prognosis of pediatric patients.
作者 方园 王一真 黎绍梅 FANG Yuan;WANG Yizhen;LI Shaomei(Department of Pathology,Anhui Provincial Children’s Hospital,Hefei 230051,China)
出处 《临床与病理杂志》 2019年第12期2727-2732,共6页 Journal of Clinical and Pathological Research
关键词 儿童 外周神经母细胞性肿瘤 临床病理因素 预后 children peripheral neuroblastic tumor clinicopathological factor prognosis
  • 相关文献

参考文献1

二级参考文献19

  • 1National cancer Institute.Surveillance Epidemiology and End Results(SEER)Database,2008.
  • 2Andrew M,Davidoff MD.Neuroblastoma.Semin Pediatr Surg,2012,21:2-14.
  • 3Nadja C,Colon MD,Dai H,et al.Neuroblastoma.Adv Pediatr,2011,58:297-311.
  • 4Suzanne Shusterman,Rani E.George.Neuroblastorna//Stuart H,David E,A Thomas Look,et al.Oncology of Infancy and Childhood,2009,14:521-524.
  • 5Kaneko M,Nishihira H,Muqishima H,et al.Stratification of treatment of stage 4neuroblastoma patients based on N-myc amplification status.Study Group of Japan for Treatment of Advanced Neuroblastoma,Tokyo,Japan.Med Pediatr Oncol,1998,31:1-7.
  • 6Ladenstein R,Philip T,Lasset C,et al.Multivariate analysis of risk factors in stage 4 neuroblastoma patients over the age of one year treated with megatherapy and stem-cell transplantation:a report from the European Bone Marrow Transplantation Solid Tumor Registry.J Clin Oncol,1998,16:953-965.
  • 7Hender TO,Bhatia S,Pinto N,et al.Racial and ethnic disparities in risk and survival in children with neuroblastoma:a Children s Oncology Group study.J clin Oncol,2011,29:76-82.
  • 8Pearson AD,Pinkerton CR,Lewis IJ,et al.High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma:a randomized trial.Lancet Oncol,2008,9:247-256.
  • 9Kreissman SG,Villablanca JG,Diller L,et al.Response and toxicity to a dose-intensive multi-agent chemotherapy induction regimen for high risk neuroblastoma(HR-NB):a Children's Oncology Group(COG A3973)study.J Clin Oncol,2007,25:95-105.
  • 10De Kraker J,Hoefnagel CA,Verschuur AC,et al.Iodine-131-metaiodobenzylguanidine as initial induction therapy in stage 4neuroblastoma patients over 1 year of age.Eur J Cancer,2008,44:551-556.

共引文献5

同被引文献33

引证文献5

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部